Research ArticleOriginal Research

Does Clinical Decision Support Increase Appropriate Medication Prescribing for Cardiovascular Risk Reduction?

David Boston, Annie E. Larson, Christina R. Sheppler, Patrick J. O’Connor, JoAnn M. Sperl-Hillen, Jennifer Hauschildt and Rachel Gold
The Journal of the American Board of Family Medicine October 2023, 36 (5) 777-788; DOI: https://doi.org/10.3122/jabfm.2022.220391R2

References

  1. 1.↵
    1. Arnett DK,
    2. Blumenthal RS,
    3. Albert MA,
    4. et al
    . 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;140:e596–e646.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Joseph JJ,
    2. Deedwania P,
    3. Acharya T
    , American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Clinical Cardiology; and Council on Hypertensionet al. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association. Circulation 2022;145:e722–e759.
    OpenUrl
  3. 3.↵
    1. Muntner P,
    2. Hardy ST,
    3. Fine LJ,
    4. et al
    . Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018. JAMA 2020;324:1190–200.
    OpenUrlPubMed
  4. 4.↵
    1. Virani SS,
    2. Alonso A,
    3. Aparicio HJ
    , American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommitteeet al. Heart disease and stroke statistics—2021 update: a report from the American Heart Association. Circulation. 2021;143:e254–e743.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Mitchell S,
    2. Roso S,
    3. Samuel M,
    4. Pladevall-Vila M
    . Unmet need in the hyperlipidaemia population with high risk of cardiovascular disease: a targeted literature review of observational studies. BMC Cardiovasc Disord 2016;16:74.
    OpenUrl
  6. 6.↵
    1. Garrett BE,
    2. Martell BN,
    3. Caraballo RS,
    4. King BA
    . Socioeconomic differences in cigarette smoking among sociodemographic groups. Prev Chronic Dis 2019;16:E74.
    OpenUrlPubMed
  7. 7.↵
    Obesity Expert Panel. Managing overweight and obesity in adults: systematic evidence review, 2013. National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services. Accessed December 8, 2020. Available at: https://www.nhlbi.nih.gov/sites/default/files/media/docs/obesity-evidence-review.pdf.
  8. 8.↵
    1. Nelson AJ,
    2. Haynes K,
    3. Shambhu S,
    4. et al
    . High-Intensity statin use among patients with atherosclerosis in the U.S. J Am Coll Cardiol 2022;79:1802–13.
    OpenUrl
  9. 9.↵
    1. Parchman ML,
    2. Pugh JA,
    3. Romero RL,
    4. Bowers KW
    . Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med 2007;5:196–201. doi:10.1370/afm.679
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Yawn B,
    2. Goodwin MA,
    3. Zyzanski SJ,
    4. Stange KC
    . Time use during acute and chronic illness visits to a family physician. Fam Pract 2003;20:474–7.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Beasley JW,
    2. Wetterneck TB,
    3. Temte J,
    4. et al
    . Information chaos in primary care: implications for physician performance and patient safety. J Am Board Fam Med 2011;24:745–51.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Jean-Jacques M,
    2. Persell SD,
    3. Thompson JA,
    4. Hasnain-Wynia R,
    5. Baker DW
    . Changes in disparities following the implementation of a health information technology-supported quality improvement initiative. J Gen Intern Med 2012;27:71–7.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Goud R,
    2. de Keizer NF,
    3. ter Riet G,
    4. et al
    . Effect of guideline based computerised decision support on decision making of multidisciplinary teams: cluster randomised trial in cardiac rehabilitation. BMJ 2009;338:b1440.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Bright TJ,
    2. Wong A,
    3. Dhurjati R,
    4. et al
    . Effect of clinical decision-support systems: a systematic review. Ann Intern Med 2012;157:29–43.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Lobach D,
    2. Sanders GD,
    3. Bright TJ,
    4. et al
    . Enabling health care decision-making through clinical decision support and knowledge management. Evid ReportTechnology Assess 2012;1–784.
  16. 16.↵
    1. Souza NM,
    2. Sebaldt RJ,
    3. Mackay JA
    , CCDSS Systematic Review Teamet al. Computerized clinical decision support systems for primary preventive care: a decision-maker-researcher partnership systematic review of effects on process of care and patient outcomes. Implement Sci 2011;6:87.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Yarnall KSH,
    2. Pollak KI,
    3. Østbye T,
    4. Krause KM,
    5. Michener JL
    . Primary care: is there enough time for prevention? Am J Public Health 2003;93:635–41.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Østbye T,
    2. Yarnall KSH,
    3. Krause KM,
    4. Pollak KI,
    5. Gradison M,
    6. Michener JL
    . Is there time for management of patients with chronic diseases in primary care? Ann Fam Med 2005;3:209–14.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Goff DC,
    2. Lloyd-Jones DM,
    3. Bennett G,
    4. et al
    . 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol 2014;63:2935–59.
    OpenUrlFREE Full Text
  20. 20.↵
    1. Koopman RJ,
    2. Kochendorfer KM,
    3. Moore JL,
    4. et al
    . A diabetes dashboard and physician efficiency and accuracy in accessing data needed for high-quality diabetes care. Ann Fam Med 2011;9:398–405.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. O'Connor PJ,
    2. Sperl-Hillen JM
    . Current status and future directions for electronic point-of-care clinical decision support to improve diabetes management in primary care. Diabetes Technol Ther 2019;21:S226–S234.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. O'Connor PJ,
    2. Sperl-Hillen JM,
    3. Rush WA,
    4. et al
    . Impact of electronic health record clinical decision support on diabetes care: a randomized trial. Ann Fam Med 2011;9:12–21.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Sperl-Hillen J,
    2. Crain L,
    3. Ekstrom H,
    4. Margolis K
    . A clinical decision support system promotes shared decision-making and cardiovascular risk factor management. J Patient-Centered Res Rev 2017;4:158–9.
    OpenUrl
  24. 24.↵
    1. Sperl-Hillen JM,
    2. Crain AL,
    3. Margolis KL,
    4. et al
    . Clinical decision support directed to primary care patients and providers reduces cardiovascular risk: a randomized trial. J Am Med Inform Assoc 2018;25:1137–46.
    OpenUrl
  25. 25.↵
    1. O’Connor P
    . Opportunities to Increase the Effectiveness of EHR-Based Diabetes Clinical Decision Support. Appl Clin Inform 2011;02:350–4.
    OpenUrl
  26. 26.↵
    1. Sperl-Hillen JM,
    2. Rossom RC,
    3. Kharbanda EO,
    4. et al
    . Priorities wizard: multisite web-based primary care clinical decision support improved chronic care outcomes with high use rates and high clinician satisfaction rates. EGEMS (Wash DC) 2019;7:9.
    OpenUrlCrossRefPubMed
  27. 27.↵
    U.S. Preventive Services Task Force. Final recommendation statement; tobacco smoking cessation in adults, including pregnant persons: interventions. January 19, 2021. Accessed April 8, 2019. Available at: https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions.
  28. 28.↵
    1. Whelton PK,
    2. Carey RM,
    3. Aronow WS,
    4. et al
    . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018;71:1269–324.
    OpenUrlCrossRefPubMed
  29. 29.↵
    American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2018. Diabetes Care 2018;41:S55–S64.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Rothwell PM,
    2. Cook NR,
    3. Gaziano JM,
    4. et al
    . Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials. Lancet 2018;392:387–99.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Casey DE,
    2. Thomas RJ,
    3. Bhalla V,
    4. et al
    . 2019 AHA/ACC clinical performance and quality measures for adults with high blood pressure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circ Cardiovasc Qual Outcomes 2019;12:e000057.
    OpenUrlPubMed
  32. 32.↵
    1. Bibbins-Domingo K,
    2. Grossman DC,
    3. Curry SJ
    , US Preventive Services Task Forceet al. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force Recommendation Statement. JAMA 2016;316:1997–2007.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Gold R,
    2. Larson AE,
    3. Sperl-Hillen JM,
    4. et al
    . Effect of clinical decision support at community health centers on the risk of cardiovascular disease: a cluster randomized clinical trial. JAMA Netw Open 2022;5:e2146519.
    OpenUrl
  34. 34.↵
    1. Kouri A,
    2. Yamada J,
    3. Lam Shin Cheung J,
    4. Van de Velde S,
    5. Gupta S
    . Do providers use computerized clinical decision support systems? A systematic review and meta-regression of clinical decision support uptake. Implement Sci 2022;17:21.
    OpenUrl
  35. 35.↵
    1. Kwan JL,
    2. Lo L,
    3. Ferguson J,
    4. et al
    . Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ. 2020;370:m3216. Published online September.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Bradley CK,
    2. Wang TY,
    3. Li S,
    4. et al
    . Patient‐reported reasons for declining or discontinuing statin therapy: insights from the PALM registry. J Am Heart Assoc 2019;8:e011765.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Hirsh BJ,
    2. Smilowitz NR,
    3. Rosenson RS,
    4. Fuster V,
    5. Sperling LS
    . Utilization of and adherence to guideline-recommended lipid-lowering therapy after acute coronary syndrome: opportunities for improvement. J Am Coll Cardiol 2015;66:184–92.
    OpenUrlFREE Full Text
  38. 38.↵
    1. Virani SS,
    2. Ballantyne CM,
    3. Petersen LA
    . Guideline-concordant statin therapy use in secondary prevention: should the medical community wait for divine intervention? J Am Coll Cardiol 2022;79:1814–7.
    OpenUrl
  39. 39.↵
    1. Wu AD,
    2. Lindson N,
    3. Hartmann-Boyce J,
    4. et al
    . Smoking cessation for secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 2022;8:CD014936.
    OpenUrl
  40. 40.↵
    1. Taylor F,
    2. Huffman MD,
    3. Macedo AF,
    4. et al
    . Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2013;2013:CD004816. Published 2013 Jan 31.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords